Born from the 2025 combination of Minaris Regenerative Medicine and WuXi Advanced Therapies, Minaris Advanced Therapies is a global contract development and manufacturing organization serving developers of cell and gene therapies. Its identity rests on a long technical lineage: more than 25 years in therapy manufacturing, over 40 years in advanced testing, and a history that includes producing the first GMP cell therapy lot in the United States in 2004. The company now supports programs from early development through commercial supply across facilities in North America, Europe and Asia.
ISO/IEC 17025:2017 accreditation
FDA drug establishment registration
Registration
EMA, PMDA, TGA and MFDS GMP compliance certificates
ISO17025
Quality certification
GMP
Quality certification
Patheon pharma servicesPatheon pharma services, part of Thermo Fisher Scientific, operates as a contract development and manufacturing organization serving biotechnology and pharmaceutical sponsors. It supports drug programs from early development and clinical supply through commercial production, and reports a global network of more than 60 locations. Its long-running specialties include viral vector manufacturing, with more than 20 years of experience, and sterile fill-finish and biologics expertise.ALLENTOWN, PA
Nitto AveciaNitto Avecia is a contract development and manufacturing organization (CDMO) specializing in the development and production of oligonucleotide therapeutics. With over 30 years of experience, the company has manufactured more than 1,200 different oligonucleotide sequences and supports programs from preclinical through commercial supply. Nitto Avecia operates FDA-inspected, GMP-compliant facilities in Massachusetts and Ohio, and is part of the Nitto Group, sharing a vision of 'Creating Wonders.'CINCINNATI, OH
CoJourneyCoJourney is a cell and gene therapy contract development and manufacturing organization that develops and produces plasmids, viral vectors, sgRNA and exosomes from process development through GMP manufacturing and analytical testing. Its distinctive Zero Chrom® column-free plasmid platform is designed for high-purity production while reducing purification time and contamination risk. With more than two decades of team experience, FDA/EMA/NMPA-compliant facilities in Hangzhou and over 100 customers served, CoJourney supports programs from early development through clinical and commercial supply.HORSHAM, PA
SK pharmtecoSK pharmteco, a subsidiary of South Korea’s SK Inc., develops and manufactures pharmaceutical therapies as a global contract development and manufacturing organization. Its seven facilities across North America, Europe, and South Korea support small-molecule and peptide programs alongside viral-vector manufacturing, with services extending from process development and analytical testing through commercial production. The company traces its CDMO business to 1996 and entered cell and gene therapy through its 2021 acquisition of French viral-vector specialist Yposkesi.KING OF PRUSSIA, PA